Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HBV genotype B/C and response to lamivudine therapy: a systematic review.

BioMed research international - 1 Jan 2013

Chen Xiu-Li, Li Man, Zhang Xiao-Lan

Abstract excerpt

A number of nucleoside analogues such as lamivudine (LAM), actually used for the treatment of chronic hepatitis B, can suppress HBV DNA replication, improve transaminase level and liver histology, and enhance the rate of hepatitis B e antigen (HBeAg) clearance. The responses to LAM therapy involve HBeAg clearance and HBV DNA conversion of negative. However, the associations between HBV genotype B/C and response...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to DNA Replication
Share to DNA, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Hepatitis B, Chronic

Share to Hepatitis B e Antigens

Share to Hepatitis B virus

Share to Lamivudine

Source

Open in PubMed Open full text

Identifiers

PMID: 24364035
DOI: 10.1155/2013/672614
PMCID: PMC3863712

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HBV genotype B/C and response to lamivudine therapy: a systematic review.PMID 24364035Read ↗

[Relationship between B virus hepatitis genotypes and therapeutic efficacy in early treatment for chronic hepatitis B by using lamivudine].Semantic proximity Read ↗

[Effects comparison of lamivudine therapy for hepatitis B virus genotypes B and C].Semantic proximity Read ↗

Relationship between hepatitis B virus genotype B and C and response to interferon therapy in HBeAg positive chronic hepatitis B patients: A meta-analysis.Semantic proximity Read ↗

Lamivudine monotherapy in chronic hepatitis B patients from the Indian subcontinent: antiviral resistance mutations and predictive factors of treatment response.Semantic proximity Read ↗

Hepatitis B virus genotypes and response to antiviral therapy.Semantic proximity Read ↗

[Polymerase region mutations and hepatitis B virus genotypes in chronic hepatitis B patients with poor response to lamivudine].Semantic proximity Read ↗

Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine.Semantic proximity Read ↗

Hepatitis B viral genotypes and lamivudine resistance.Semantic proximity Read ↗

Hepatitis B genotypes and response to antiviral therapy: a review.Semantic proximity Read ↗

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.Semantic proximity Read ↗

[The influence of HBV genotypes on the therapeutic effects of lamivudine in chronic hepatitis B patients].Semantic proximity Read ↗

Hepatitis B virus subtypes and lamivudine resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.